| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |